Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Default user image.

Carsten Peterson

Expert

Default user image.

Detection of pancreatic cancer using antibody microarray-based serum protein profiling

Författare

  • Johan Ingvarsson
  • Christer Wingren
  • Anders Carlsson
  • Peter Ellmark
  • Britta Wahren
  • Gunilla Engström
  • Ulrika Harmenberg
  • Morten Krogh
  • Carsten Peterson
  • Carl Borrebaeck

Summary, in English

The driving force behind oncoproteomics is to identify protein signatures that are associated with a particular malignancy. Here, we have used a recombinant scFv antibody microarray in an attempt to classify sera derived from pancreatic adenocarcinoma patients versus healthy subjects. Based on analysis of nonfractionated, directly labeled, whole human serum proteomes we have identified a protein signature based on 19 nonredundant analytes, that discriminates between cancer patients and healthy subjects. Furthermore, a potential protein signature, consisting of 21 protein analytes, could be defined that was shown to be associated with cancer patients having a life expectancy of <12 months. Taken together, the data suggest that antibody microarray analysis of complex proteomes will be a useful tool to define disease associated protein signatures.

Avdelning/ar

  • Institutionen för immunteknologi
  • Computational Biology and Biological Physics

Publiceringsår

2008

Språk

Engelska

Sidor

2211-2219

Publikation/Tidskrift/Serie

Proteomics

Volym

8

Issue

11

Dokumenttyp

Artikel i tidskrift

Förlag

John Wiley & Sons Inc.

Ämne

  • Immunology in the medical area
  • Biophysics

Aktiv

Published

ISBN/ISSN/Övrigt

  • ISSN: 1615-9861